Bioventus Net Debt Growth & History (BVS)
Bioventus's net debt was $260.1M for fiscal 2025.
View full Bioventus company overviewBioventus annual net debt history
2020
2021
2022
2023
2024
2025
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $260.1M | −$54.4M | −17.29% |
| 2024 | 2024-12-31 | $314.5M | −$69.2M | −18.03% |
| 2023 | 2023-12-31 | $383.7M | −$22.3M | −5.48% |
| 2022 | 2022-12-31 | $405.9M | $73.6M | +22.16% |
| 2021 | 2021-12-31 | $332.3M | $214.7M | +182.54% |
| 2020 | 2020-12-31 | $117.6M | — | — |
Bioventus quarterly net debt
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-27 | $234.3M | −$93.5M | −28.51% |
| Q1 2026 | 2026-03-28 | $252.6M | −$90.8M | −26.43% |
| Q4 2025 | 2025-12-31 | $260.1M | −$54.4M | −17.29% |
| Q3 2025 | 2025-09-27 | $299.0M | −$63.0M | −17.40% |
| Q2 2025 | 2025-06-28 | $327.7M | −$45.8M | −12.27% |
| Q1 2025 | 2025-03-29 | $343.3M | −$47.4M | −12.13% |
| Q4 2024 | 2024-12-31 | $314.5M | −$69.2M | −18.03% |
| Q3 2024 | 2024-09-28 | $362.0M | −$32.6M | −8.26% |
| Q2 2024 | 2024-06-29 | $373.6M | −$10.9M | −2.83% |
| Q1 2024 | 2024-03-30 | $390.7M | −$32.1M | −7.59% |
| Q4 2023 | 2023-12-31 | $383.7M | −$22.3M | −5.48% |
| Q3 2023 | 2023-09-30 | $394.6M | −$13.1M | −3.20% |
| Q2 2023 | 2023-07-01 | $384.4M | $31.8M | +9.01% |
| Q1 2023 | 2023-04-01 | $422.8M | $61.8M | +17.11% |
| Q4 2022 | 2022-12-31 | $405.9M | $73.6M | +22.16% |
| Q3 2022 | 2022-10-01 | $407.6M | $292.9M | +255.40% |
| Q2 2022 | 2022-07-02 | $352.7M | $288.7M | +451.66% |
| Q1 2022 | 2022-04-02 | $361.0M | $281.2M | +352.18% |
| Q4 2021 | 2021-12-31 | $332.3M | $214.7M | +182.54% |
| Q3 2021 | 2021-10-02 | $114.7M | — | — |
| Q2 2021 | 2021-07-03 | $63.9M | — | — |
| Q1 2021 | 2021-04-03 | $79.8M | — | — |
| Q4 2020 | 2020-12-31 | $117.6M | — | — |
Bioventus net debt trends
Over the last five fiscal years, Bioventus's net debt increased from $117.6M to $260.1M, a change of $142.5M. The latest reported quarter, Q2 2026, shows $234.3M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bioventus source filings ↗